Biocontrol of Aspergillus and Fusarium Mycotoxins in Africa : benefits and limitations by Kagot, Victor Omondi et al.
toxins
Opinion
Biocontrol of Aspergillus and Fusarium Mycotoxins in
Africa: Benefits and Limitations
Victor Kagot 1,2, Sheila Okoth 2 , Marthe De Boevre 1,* and Sarah De Saeger 1
1 MYTOX-SOUTH, Centre of Excellence in Mycotoxicology and Public health, Ghent University, 9000 Ghent,
Belgium; victor.kagot@ugent.be (V.K.); sarah.desaeger@ugent.be (S.D.S.)
2 Centre for Biotechnology and Bioinformatics, University of Nairobi, Nairobi 00100, Kenya;
dorisokoth@yahoo.com
* Correspondence: marthe.deboevre@ugent.be; Tel.: +32-9-264-8134
Received: 16 January 2019; Accepted: 6 February 2019; Published: 13 February 2019


Abstract: Fungal contamination and the consequent mycotoxin production is a hindrance to food
and feed safety, international trade and human and animal health. In Africa, fungal contamination
by Fusarium and Aspergillus is heightened by tropical climatic conditions that create a suitable
environment for pre- and postharvest mycotoxin production. The biocontrol of Fusarium and
its associated fusariotoxins has stagnated at laboratory and experimental levels with species of
Trichoderma, Bacillus and atoxigenic Fusarium being tested as the most promising candidates. Hitherto,
there is no impetus to upscale for field use owing to the inconsistent results of these agents.
Non-aflatoxigenic strains of Aspergillus have been developed to create biocontrol formulations by
outcompeting the aflatoxigenic strains, thus thwarting aflatoxins on the target produce by 70% to
90%. Questions have been raised on their ability to produce other mycotoxins like cyclopiazonic acid,
to potentially exchange genetic material and to become aflatoxigenic with consequent deleterious
effects on other organisms and environments. Other biocontrol approaches to mitigate aflatoxins
include the use of lactic acid bacteria and yeast species which have demonstrated the ability to
prevent the growth of Aspergillus flavus and consequent toxin production under laboratory conditions.
Nevertheless, these strategies seem to be ineffective under field conditions. The efficacy of biological
agents is normally dependent on environmental factors, formulations’ safety to non-target hosts and
the ecological impact. Biocontrol agents can only be effectively evaluated after long-term use, causing
a never-ending debate on the use of live organisms as a remedy to pests and diseases over the use of
chemicals. Biocontrol should be used in conjunction with good agricultural practices coupled with
good postharvest management to significantly reduce mycotoxins in the African continent.
Keywords: aflatoxins; fumonisins; biocontrol; Aspergillus; Fusarium; Africa
Key Contribution: This paper pinpoints the advantages and potential limitations of biocontrol
strategies against Aspergillus and Fusarium mycotoxins in Africa. We highlight the need to implement
a multi-factorial approach to mitigate mycotoxin levels in food and feed within the African continent.
1. Introduction
Mycotoxins are secondary metabolites produced by filamentous fungi as a strategy to secure
an ecological advantage over other organisms which share their ecosystem and enhance their fitness
against extreme environments. Under specific environmental conditions, a variety of fungi such as
Aspergillus, Penicillium, Fusarium and Claviceps spp. colonize their host and produce mycotoxins [1].
Over 300 mycotoxins have been identified, with approximately 30 being recognized to have adverse
health effects on vertebrates upon ingestion [1,2]. Some of these toxins trigger immune deficiency,
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lower production in livestock and are carcinogenic [3]. Unfortunately, once contaminated, feed or food
containing mycotoxins are condemned because these toxins are resilient and stable against thermal,
physical and chemical treatments during food processing. This poses a hurdle in free trade and food
security since contaminated food and feed ends up as discarded waste [2,3].
Fusarium and Aspergillus are aerobic fungi with oligotrophic capabilities. They have a
geographically global distribution, mostly found in terrestrial habitats ranging from soil, plants,
other organisms and human-made substrates [4,5]. In the environment, they play a crucial role in
decomposition and the cycling of nutrients, and have the potential for exploitation in bioremediation,
biocontrol and bio-detoxification [6,7]. In industry, members of the Aspergillus genus have been
utilized to produce organic acids, extracellular enzymes and beneficial secondary metabolites like
lovastatin [8], while members of the Fusarium genus are being used in the production of mycoproteins,
distributed under the brand name Quorn as a meat-substitute in foods [9]. In human, animal and
plant health, these fungi can cause diseases either through invasive growth, which is common and
fatal in immunosuppressed organisms, or through the consumption of food or feed contaminated with
mycotoxins [10,11]. Mycotoxins cause enormous economic losses ranging from loss of life, decreased
production in animals and increased costs of veterinary and human health care services. Under severe
contaminations, total losses are experienced when the produce is declared unfit for consumption,
rejected by the market and consequently destroyed [12].
In Africa, approximately 0.5 billion people are at risk of chronic exposure to aflatoxins through
the consumption of maize and other foodstuffs prone to Aspergillus proliferation. Aflatoxin exposure
surveys have confirmed the presence of aflatoxins in infant blood samples from Ghana, Kenya, Nigeria,
Sudan, Benin, Togo, Egypt and Gambia [13]. Parts of the continent have reported widespread stunting
in children, immune suppression and in some cases child neurological impairment traits linked to
chronic dietary consumption of aflatoxins [13–15]. In Kenya, loss of life has been reported repeatedly
from acute aflatoxicosis [13,16,17]. Currently, mitigation measures in place include regulations which
impose maximum limits or guidance values of mycotoxins in food and feed to avert future untimely
loss of life from the consumption of mycotoxin-contaminated food. Several African countries have
put up country-specific regulations which set maximum limits for aflatoxins, including Kenya, Egypt,
Mozambique, Tanzania and Nigeria (sum of aflatoxins B1, B2, G1 and G2, 10 µg/kg). South Africa,
Tunisia and Zimbabwe targeted this level at 5 µg/kg [18]. Available mitigation technologies like the
use of hermetic storage is too expensive for small-scale farmers and the developing governments [12].
Fusarium mycotoxins have not been given much attention in Africa, despite correlation studies
suggesting links between Fusarium and fumonisin incidence and increasing human esophageal
carcinomas in parts of South Africa and Kenya [18,19]. Unlike aflatoxins, which have caused
documented loss of life in Africa, the actual repercussions of consumption of fumonisins and other
Fusarium mycotoxins remain inferential. Occurrences of fumonisins in food crops and products have
been reported across Africa, with countries like Botswana, Burkina Faso, Cameroon, Congo, Ivory
Coast, Ghana, Kenya, Malawi, Mozambique, Nigeria, Benin, South Africa, Zambia and Zimbabwe
recording samples with fumonisin levels larger than 1000 µg/kg [4]. Despite the known occurrence
and contamination levels of fumonisins, many African countries do not have regulations aimed at
controlling and monitoring fumonisins or other Fusarium mycotoxins. Consequently, control strategies
have stagnated at laboratory and experimental levels with no impetus to upscale for field use [4,19].
The mycotoxin problem in Africa only comes to the limelight when there is an outbreak
and lives are lost. During that period, regulation is enforced and contaminated food and feed is
impounded and destroyed. However, shortly after the regulation becomes unenforceable owing to
weak non-sustainable institutions. In this part of the world, the population is at a serious risk of chronic
exposure to mycotoxins since regulation is seldom enforced. Moreover, the poorest might prefer to
consume cheap, physically damaged and visibly discolored maize which is potentially contaminated
with mycotoxins. The anxiety of future repercussions is not taken into account when faced with the
prospect of starvation [20].
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The burden of chronic exposure in humans to mycotoxins in Africa is a matter of scientific
discourse since there is a lack of data to ascertain the level of harm that the toxins actually cause.
Emerging control strategies have not been adopted by farmers owing to their inaccessibility and the
prohibiting cost. Besides, no single mitigation measure has proven to be robust enough for wide-scale
adoption in Africa—each approach has its own merits and demerits. These interventions can be
divided into pre- and postharvest, and successful control strategies should encompass approaches
which control toxins both preharvest/farm and postharvest/storage [21]. An upcoming preharvest
management strategy is breeding, which employs both conventional and transgenic technologies to
identify and enhance plants with resistance to mycotoxin contamination and fungal ear rot. So far,
using such efforts, the International Crops Research Institute for the Semi-Arid Tropics (ICRISAT) has
reported a peanut variety resistant to aflatoxin contamination [22]. In similar studies by Okoth et al.
(2017), conducted in Kenya and South Africa, maize inbred lines CML247, CML444, CML495, LaPosta,
CML 390 and CB222 demonstrated resistance to Aspergillus ear rot and aflatoxin contamination. Some
of these lines like CB222, CML444 and CML390 were resistant not only to aflatoxins, but also to
fumonisins and Fusarium ear rot [23].
Governments across Africa have intensified campaigns on good agricultural practices as a strategy
to reduce the toxin load in food. Farmers are being urged to select healthy seeds, practice crop rotation,
plant in good time (just at the onset of rain) and maintain optimal seed density. These are factors
which generally reduce the fungal load in the soil and consequent toxin contamination. [24]. The use
of biocontrol agents as a strategy against the toxins has emerged as a strong preharvest method as it
has consistently reduced aflatoxin contamination by 70% to 90% both in laboratory and field trials [25].
Postharvest methods include proper drying and the use of hermetic storage devices. These have
been shown to possess the capability to arrest the mycotoxin increase in the stored grains by
depriving the toxigenic fungus of oxygen, hence preventing further development and consequent toxin
production [21]. Sorting options have been suggested and tested using near-infrared hyperspectral
imaging devices to detect aflatoxin-contaminated maize and peanuts [26]. Smallholder farmers
are encouraged to practice hand sorting where physically infected grains are removed, which can
significantly reduce mycotoxin concentration in the sorted grain [27]. The use of binders is a
promising strategy since it is being practiced in the livestock and poultry industry. Binders reduce the
bioavailability of mycotoxins in the gastrointestinal tract by adhering to the toxins, rendering them
not absorbable [28]. The use of binders in humans has been tried in Africa. In Ghana, NovaSil clay
was effective in decreasing exposure to aflatoxin [29]. In Kenya, the Centre for Disease Control (CDC)
conducted binder trials using human subjects with promising results in 2015 [13]. The use of binders
has had skeptics questioning effects of binders on the adsorption of other nutrients and minerals
essential for normal body functioning.
Stakeholders in Africa have only focused on aflatoxins with little or no attention given to other
mycotoxins, yet analysis pinpoints the existence of fumonisins among other toxins. Farmers, despite
being aware of the threats posed by mycotoxins, are slow to adopt any mycotoxin mitigation technology
which involves them spending more money since the contamination process is invisible, and the
produce does not fetch an increased premium for being toxin-free. Often of importance to the farmer
is controlling insect damage and maintaining high grain quality parameters which might attract a high
price in the market [21]. Research has revealed the negative impacts of fumonisins and aflatoxins on
human and animal health, food security and trade across Africa [13,19]. The fear exists that millions
are consuming doses of these mycotoxins in their daily food intake.
Several technologies are being tested and promoted for mycotoxin management. The use of
biocontrol agents as a strategy against mycotoxins is rapidly being adopted across African nations.
This opinion paper attempts to analyze the types of biocontrol on Aspergillus and Fusarium mycotoxins
present on the African continent, the extent of adoption and possible challenges facing this technology
in Africa.
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2. Biocontrol of Aspergillus Mycotoxins in Africa
The Aspergillus genus consists of a diverse assemblage of microorganisms that produce a wide
range of mycotoxins. A. versicolor and A. nidulans produce sterigmatocystin; A. ochraceus produces
ochratoxin, citrinin, viomellein and penicillic acid; and A. clavatus produces patulin. Other metabolites
synthesized by the fungus include aflatrem, aflavinine, kojic acid, flavocol, aspergillic acid, aspertoxin,
cyclopiazonic acid, paspallinine and aflatoxins [30]. On the other hand, A. terreus produces lovastatin,
an anti-cholesterol agent, and A. fumigatus produces verruculogen and helvolic acid, which exhibit
anti-fungal activities. Aflatoxins are the most potent natural carcinogens and up to 20 members of the
Aspergillus genus—assigned to three sections, Flavi, Nidulantes and Ochraceorosei—have been reported to
be toxigenic. A. flavus is the most virulent species in terms of toxin production [13,31–34]. The fungus
exhibits a high genetic diversity within its populations, mostly as a result of sexual reproduction
characterized by the formation of ascospore-bearing ascocarps inside sclerotia. Genetic recombination
is possible between strains of opposite mating types since the fungus is heterothallic [35].
A. flavus comprises an assemblage of phylogenetically-related aflatoxin and non-aflatoxin
producing strains with the toxin production varying dependent on the isolate. The fungus is divided
into S and L morphotypes. The S morphotypes produce, on average, much higher aflatoxins than the
L morphotypes. Each morphotype is further divided into vegetative compatibility groups (VCGs)
determined by a series of het loci. Individuals belonging to compatible VCGs have successful hyphal
fusion and transfer of genetic material, while the transfer of genetic material amongst individuals of
incompatible groups is not possible. In this regard some isolates produce no aflatoxins at all, and are
termed atoxigenic. The aflatoxin-producing ability tends to be similar among members of the same
VCG [13,36]. Efforts to control aflatoxin contamination have involved the use of non-aflatoxigenic
strains of Aspergillus as biocontrol agents to outcompete aflatoxigenic strains. In 1990, in the Arizona
cotton fields, Cotty [37] demonstrated that wounded cotton bolls recorded lower levels of aflatoxin in
the cotton seeds compared to cotton seeds of wounded bolls inoculated with aflatoxigenic strains alone
while simultaneously inoculated with aflatoxigenic and non-aflatoxigenic A. flavus strains. In addition,
aflatoxin levels were further reduced when non-aflatoxigenic strains were inoculated one day before
inoculating aflatoxigenic strains. Also, the levels of aflatoxins did not reduce when aflatoxigenic
strains were inoculated before their non-aflatoxigenic counterparts [37]. This phenomenon has been
described as competitive exclusion, where the non-aflatoxigenic strains effectively compete for space
and nutrients, thus excluding their aflatoxigenic counterparts.
Large-scale studies over the years have led to the development of biocontrol agents for commercial
application based on the ability of non-aflatoxigenic strains to reduce aflatoxin contamination
in cotton seeds, peanuts and corn. Such products include aflaguard® and AF36® registered by
the USA Environmental Protection Agency, and Aflasafe® registered in Nigeria and Kenya [11].
These formulations are based on the fact that non-aflatoxigenic strains outcompete aflatoxigenic
strains, leading to their incapability to synthesize aflatoxins. Another factor is that aflatoxigenic and
non-aflatoxigenic strains are selected based on their vegetative incompatibility, which limits sexual
reproduction and exchange of genetic material through the parasexual cycle, ensuring the stability of
the biocontrol formulation [38].
In both Kenya and Nigeria (where Aflasafe® is commercialized), specific requirements had to
be met before registration. In Nigeria, the National Agency for Food and Drug Administration and
Control (NAFDAC) required that poultry feed on Aflasafe®-treated sorghum be investigated to assess
the products’ safety. In Kenya, the Pest Control Products Board (PCPB) required toxicological and
eco-toxicological studies to be conducted. In Senegal, Ghana, Burkina Faso, Tanzania and Zambia, the
development of the formulations is at an advanced stage and are due for registration. In Mozambique
and Malawi, the formulations are under testing in farmers’ fields, and in Ethiopia and Uganda, the
formulations are at strain development. Other African countries like Mali and the D.R. Congo are also
expressing their interest [39].
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Lactic acid bacteria (Lactobacillus (L.) casei and L. reuteri) have demonstrated the ability to bind
with aflatoxins in aqueous solutions. Hathout et al. (2011) observed that aflatoxin-induced stress
in rats, leading to debilitating health and deteriorating liver functions, was restored to health by
treatment with lactic acid bacteria. In other in vitro tests, L. amylovorus and L. rhamnosus demonstrated
the ability to bind up to 60% AFB1, showing their potential to bind and lock-up selected dietary
contaminants [40,41]. In similar tests L. rhamnosus reduced the uptake of AFB1 by 74% in chicken
intestinal tissue, suggesting their potential for exploitation as toxin binders. Incorporating lactic acid
bacteria in diets offers a feasible approach to reduce chronic exposure to aflatoxins [42]. In other
laboratory assays, Pseudomonas spp. and Bacillus strains demonstrated the ability to inhibit growth
of Aspergillus and consequent toxin production. Some of these soil bacteria were found to produce
aflatoxin inhibitors [43]. However, these bacteria were not effective against aflatoxin production and
fungal growth in field conditions owing to the difficulty in handling pure bacterial cultures under field
conditions. In other assays, saprophytic yeasts like Pichia anomala and Candida krusei have demonstrated
efficacy against A. flavus and aflatoxin production in the laboratory. The yeasts also possess aflatoxin
binding capabilities similar to the lactic acid bacteria; nevertheless, they have reported little success in
the field [43,44].
3. Biocontrol of Fusarium Mycotoxins in Africa
Fusarium is a genus of filamentous fungi with perfect state members belonging to the genera
Gibberella, Calonectria, Nectria and Microneciriella. The fungus is ubiquitous, and a notorious
plant-pathogen to most food crops causing annual losses of millions of US dollars. In addition to
causing an array of plant diseases, some members of the Fusarium genus produce deleterious secondary
metabolites such as fumonisins, zearalenone and trichothecenes, known to cause devastating health
complications in humans and animals [4,45].
Several biological control agents have been tested as suitable candidates against
fumonisin-producing F. verticilloides. The strategy is to have a biological formulation which can
outcompete the toxin-producing strains and end up with a toxin-free product. Atoxigenic F.
verticilloides showed great promise in excluding their toxigenic counterparts; however, since they
are plant pathogens, they resulted in a higher disease incidence [19]. The use of endophytic bacteria
Bacillus subtilis demonstrated potential in precluding fungal hyphae and consequent toxin production.
The bacteria reduced the amount of fumonisins produced by up to 50% since the bacteria is an
ecological homologue to the fungus and it inhibits fungal growth through the competitive exclusion
principle [46]. When Bacillus amyloliquefaciens and Microbacterium oleovorans were applied as seed
coatings at a concentration of 107 colony-forming units per millimeter, both had the ability to reduce
fumonisin B1 and B2 in maize grains [47]. Trichoderma strains have shown good antibiosis and
parasitism ability for exploitation as mycoparasites against toxigenic Fusarium isolates. A dual-culture
bioassay on potato dextrose agar medium showed that Trichoderma outcompeted Fusarium by forming
coils around the Fusarium hyphae, penetrating it and thus preventing the growth [19,48].
In vitro tests on wheat and maize grains showed that inoculation with Microsphaerosis species
reduces Gibberella zeae ascospore production by 73% [49]. In other tests, inoculation of wheat ears
with Phoma betae under glass house conditions reduced the severity of Fusarium head blight by up to
60%. Under similar conditions, Pythium ultimum induced a prolonged latency in F. nivale, delaying
the disease onset [49]. Bacillus spp. have also been tested under glass house conditions and the
Bacillus strain AS 43.4 was found to decrease the concentration of deoxynivalenol (DON) in grain by
89–97% [49]. In other laboratory tests rhizobacteria including Azotobacter, Bacillus, Pseudomonas and
Arthrobacter reduced fumonisin B1 production and showed an ability to thwart F. verticolloides [50].
These tests demonstrate a potential for the biocontrol of Fusarium and consequently its mycotoxins.
However, in field conditions these antagonistic strains give inconsistent results. The need for more
research on their potential upscale and field use in Africa is imperative.
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4. Potential Limitations and Benefits
Benefits of biocontrol formulations as a remedy against mycotoxins and especially aflatoxins in
Africa have been documented as this strategy has reduced aflatoxin contamination by 70% to 90% both
in laboratory and field trials [25]. However, this approach has attracted scrutiny from stakeholders
in industry, academia and local governments who question its safety, sustainability, effects on other
mycotoxins and its impact on the ecosystem [39]. A critique of this approach would be the fact that
these biocontrol agents are being selected based on their inability to produce aflatoxins. However, both
non-aflatoxigenic and aflatoxigenic Aspergillus strains have the ability to produce other mycotoxins or
metabolites detrimental to humans and animals upon consumption. An example is cyclopiazonic acid
(α-CPA), which is an enzyme (ATP-ase) inhibitor with the potential to affect normal muscle contraction
and relaxation produced by the non-aflatoxigenic Aspergillus AF36, formally used in biocontrol
formulations to mitigate aflatoxins in the USA. Currently, other non-aflatoxigenic strains which
cannot synthesize α-CPA are being utilized as biocontrol agents in replacement of AF36 [51]. However,
it should be taken into consideration that other CPA derivatives such as indole derivatives, speradines,
aspergillines and cyclopiamides do exist. Hence, a more thorough (toxicological) assessment of these
fungal metabolites is needed [52]. Moreover, A. flavus strains can synthesize an array of metabolites
with unknown toxicological effects such as kojic acid, aflavinine, aspertoxin, aflatrem, paspalinine,
leporin C and sterigmaticystin [30]. In each country where this technology is in use, country-specific
regulations must be met prior to registration and adaptation. Fears of potential harm are reduced by
risk assessment tests focusing on the biocontrol formulations as allergens to the skin and eye as well as
effects on inhalation [39].
In addition, the use of biocontrol agents (e.g., Trichoderma) can affect biosynthetic fungal
metabolic pathways leading to the conversion of mycotoxins into modified derivatives. The occurrence
of these modified forms eventually leads to an underestimation of the overall mycotoxin content in a
specific crop.
Recent studies have reported the existence of the sexual state of Aspergillus with sexual
reproduction being observed in individuals belonging to different VCGs. Further, crossing sexually
compatible strains in the laboratory has shown that the ability to produce aflatoxins can be passed
from parent to progeny, suggesting the possibility that a non-aflatoxigenic strain can become toxigenic
through sexual reproduction [53]. Nonetheless, if this occurs it is also possible that the atoxigenic
strains can transfer atoxigenicity to their toxigenic counterparts and yield progenies without the ability
to produce aflatoxins [39]. Questions on effects of introducing live microbes to the environment and
the potential harm that the introduced inoculum could pose to other microbes and not target organisms
have been raised. In this case, these biocontrol formulations should contain microorganisms native to
the area of application, which potentially pose no harm to unintended individuals [39]. The influence
of these biocontrol formulations on other mycotoxins—particularly fumonisins—is of concern [54].
In this regard, the use of atoxigenic Aspergillus strains against their toxigenic counterparts is primarily
designed to tackle aflatoxins, with no reduction expected on other mycotoxins. Tests carried out by the
developer in Nigeria between 2009 and 2012 demonstrated that the application of Aflasafe® did not
significantly affect the occurrence of fumonisins in treated and control fields [39]. More tests on safety
and sustainability should, however, be elaborated to eradicate any doubt on potential deleterious
effects on human and plant health and the environment.
5. Conclusions
Although the use of biocontrol formulations as a strategy against mycotoxins has raised concern,
this approach has shown an ability to reduce aflatoxin contamination in grains. As with any new
biocontrol technology, its actual effects can only be evaluated after long-term use. In the meantime,
all stakeholders should be equipped with adequate information on the handling, application and
potential risks posed by these biological formulations. Moreover, biocontrol alone will not be sufficient
but should be used in conjunction with good agricultural practices coupled with good postharvest
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management like sorting and proper storage, preferably in hermetic devices to significantly reduce
mycotoxins in the African continent. Research and development on these formulations should not
cease so as to ensure the sustainability and safety of these formulations.
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